Clinical Study
Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson’s Disease Utilizing LSVT BIG®
Table 4
Primary outcomes and MCID.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meeting MCID required improvement in performance from baseline. For Functional Gait Assessment, 2 of 9 participants’ baseline was so high that improvement at a level of MCID was not possible. In fact, participant 8 was at the maximum score possible (=30) at baseline. For Berg, 4 of 9 participants’ baseline was so high that improvement at a level of MCID was not possible. For UPDRS, 1 participant’s baseline was so low that improvement at a level of MCID was not possible. Participant 8 scored well on functional assessments at baseline on the FGA, Berg, andUPDRS, so improvement at a level of MCID was not possible to achieve. |